Skip to main content
. 2017 Aug 9;23:235–246. doi: 10.2119/molmed.2017.00084

Table 1.

Characteristics of patients and CIK cells.

Age/Gender CD3+CD56+ Day 0 (%) CD3+CD56+ Day14 (%) CD3+CD56+ Day 21 (%) CD3+ Day 21 (%) CD3+CD8+ Day 21 (%) CD3+NKG2D+ Day 21 (%) Expansion (Fold)
PT1 59/F 3 25 40 99 81 90 119
PT2 60/M 4 10 19 98 71 76 33
PT3 64/M 7 32 34 99 59 80 68
PT4 65/M 4 9 15 99 78 82 191
PT5 66/M 5 28 33 97 76 88 81